TREATMENT EVALUATION IN PREMENSTRUAL SYNDROME PATIENTS

经前综合症患者的治疗评估

基本信息

  • 批准号:
    6351371
  • 负责人:
  • 金额:
    $ 30.9万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1985
  • 资助国家:
    美国
  • 起止时间:
    1985-02-01 至 2002-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION: Premenstrual syndrome (PMS) is a complex, chronic, menstrually-related disorder, which is reported at severe levels that impairs functioning by 5-10 percent of reproductive-age women. Severe PMS is associated with diminished productivity, lost work time in the prime years of life, and troubled interpersonal relationships, particularly with the partner and children. Only in recent years, and resulting from these studies and other research, has there been scientific information on the efficacy and safety of treatments and investigation of the etiology of PMS. The investigators conceptualize PMS as mood and behavioral changes that derive from central effects, possibly an altered central nervous system (CNS) sensitivity involving changes of gonadal-adrenal steroids. Building on findings of serotonergic involvement in PMS symptoms, the investigators propose to complete and extend studies of the efficacy and safety of serotonergic antidepressant treatment for PMS. The aims of this competing renewal application are to: 1) complete a large clinical study comparing the efficacy of a serotonergic and a noradrenergic antidepressant with a sample size sufficient for definitive results; 2) conduct a randomized, double-blind, placebo-controlled study of intermittent dosing with sertraline administered in the symptomatic premenstrual phase compared to daily dosing; and 3) examine the impact of PMS on functioning, productivity, health care utilization and quality of life before and after medical treatment in aim #1.
经前综合症(PMS)是一种复杂的慢性、

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ELLEN W FREEMAN其他文献

ELLEN W FREEMAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ELLEN W FREEMAN', 18)}}的其他基金

Efficacy of an SSRI for Menopausal Symptoms in Perimenopausal Women
SSRI 对围绝经期女性更年期症状的功效
  • 批准号:
    7533564
  • 财政年份:
    2008
  • 资助金额:
    $ 30.9万
  • 项目类别:
Efficacy of an SSRI for Menopausal Symptoms in Perimenopausal Women
SSRI 对围绝经期女性更年期症状的功效
  • 批准号:
    7923832
  • 财政年份:
    2008
  • 资助金额:
    $ 30.9万
  • 项目类别:
Efficacy of an SSRI for Menopausal Symptoms in Perimenopausal Women
SSRI 对围绝经期女性更年期症状的功效
  • 批准号:
    8135398
  • 财政年份:
    2008
  • 资助金额:
    $ 30.9万
  • 项目类别:
Efficacy of an SSRI for Menopausal Symptoms in Perimenopausal Women
SSRI 对围绝经期女性更年期症状的功效
  • 批准号:
    8312529
  • 财政年份:
    2008
  • 资助金额:
    $ 30.9万
  • 项目类别:
Efficacy of an SSRI for Menopausal Symptoms in Perimenopausal Women
SSRI 对围绝经期女性更年期症状的功效
  • 批准号:
    7682127
  • 财政年份:
    2008
  • 资助金额:
    $ 30.9万
  • 项目类别:
Core symptoms and profiles in premenstrual syndrome
经前综合症的核心症状和概况
  • 批准号:
    7319434
  • 财政年份:
    2007
  • 资助金额:
    $ 30.9万
  • 项目类别:
Core symptoms and profiles in premenstrual syndrome
经前综合症的核心症状和概况
  • 批准号:
    7489355
  • 财政年份:
    2007
  • 资助金额:
    $ 30.9万
  • 项目类别:
CAREER DEVELOPMENT IN WOMEN'S HEALTH RESEARCH AND GENDE*
女性健康研究和性别领域的职业发展*
  • 批准号:
    6949089
  • 财政年份:
    2002
  • 资助金额:
    $ 30.9万
  • 项目类别:
CAREER DEVELOPMENT IN WOMEN'S HEALTH RESEARCH AND GENDE*
女性健康研究和性别领域的职业发展*
  • 批准号:
    7103649
  • 财政年份:
    2002
  • 资助金额:
    $ 30.9万
  • 项目类别:
EPIDEMIOLOGY STUDY OF THE LATE REPRODUCTIVE YEARS
生育后期的流行病学研究
  • 批准号:
    6565771
  • 财政年份:
    2001
  • 资助金额:
    $ 30.9万
  • 项目类别:

相似海外基金

Alprazolam and Simulated Driving Performance: Next Day Effects
阿普唑仑和模拟驾驶表现:次日效应
  • 批准号:
    9455117
  • 财政年份:
    2017
  • 资助金额:
    $ 30.9万
  • 项目类别:
fMRT-Untersuchung der Effekte von Alprazolam auf die experimentelle Auslösbarkeit von Panikattacken mit Cholezystokinin-Tetrapeptid (CCK-4) bei gesunden Probanden
fMRI 研究阿普唑仑对胆囊收缩素四肽 (CCK-4) 实验诱导健康受试者惊恐发作的影响
  • 批准号:
    109180591
  • 财政年份:
    2009
  • 资助金额:
    $ 30.9万
  • 项目类别:
    Research Grants
Alprazolam Abuse Liability in Post Traumatic Stress Disorder (PTSD)
创伤后应激障碍 (PTSD) 中阿普唑仑滥用的责任
  • 批准号:
    7257589
  • 财政年份:
    2008
  • 资助金额:
    $ 30.9万
  • 项目类别:
Alprazolam Abuse Liability in Post Traumatic Stress Disorder (PTSD)
创伤后应激障碍 (PTSD) 中阿普唑仑滥用的责任
  • 批准号:
    7628407
  • 财政年份:
    2008
  • 资助金额:
    $ 30.9万
  • 项目类别:
BEHAVIORAL AND REINFORCING EFFECTS OF ALPRAZOLAM IN MONKEYS
阿普唑仑对猴子的行为和强化作用
  • 批准号:
    7349547
  • 财政年份:
    2006
  • 资助金额:
    $ 30.9万
  • 项目类别:
NALTREXONE AND ALPRAZOLAM-INDUCED FMRI CHANGES
纳曲酮和阿普唑仑引起的 FMRI 变化
  • 批准号:
    7379477
  • 财政年份:
    2005
  • 资助金额:
    $ 30.9万
  • 项目类别:
NALTREXONE AND ALPRAZOLAM-INDUCED FMRI CHANGES IN ALCOHOLISM
纳曲酮和阿普唑仑引起的酗酒 FMRI 变化
  • 批准号:
    7206274
  • 财政年份:
    2004
  • 资助金额:
    $ 30.9万
  • 项目类别:
Naltrexone and Alprazolam-induced fMRI Changes
纳曲酮和阿普唑仑引起的功能磁共振成像变化
  • 批准号:
    7042200
  • 财政年份:
    2003
  • 资助金额:
    $ 30.9万
  • 项目类别:
Naltrexone and alprazolam-induced fMRI changes
纳曲酮和阿普唑仑引起的功能磁共振成像变化
  • 批准号:
    6621891
  • 财政年份:
    2002
  • 资助金额:
    $ 30.9万
  • 项目类别:
EFFECTS OF REBOXETINE & NEFAZODONE ON PHARMACOKINETICS OF ALPRAZOLAM
瑞博西汀的作用
  • 批准号:
    6653451
  • 财政年份:
    2002
  • 资助金额:
    $ 30.9万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了